Oncology Clinical Trials in Santa Rosa, CA

As of August 2026, 44 paid clinical trials are recruiting for Oncology in Santa Rosa, California. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 31, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

44 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Santa Rosa, CA.

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

for Solid Tumor

Drug: INBRX-106

Sites in Santa Rosa, Glendale +11 more locations

Sponsor: Inhibrx Biosciences, Inc

Sex: All·Age: 18+

Code: NCT04198766·Phase 1, Phase 2·Recruiting·Listed Dec 2019

Apply to this trial

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

for Gastric Cancer

Sites in Santa Rosa, Palo Alto +5 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06219941·Phase 2·Recruiting·Listed Jan 2024

Apply to this trial

A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)

for Non-Small Cell Lung Cancer

Sites in Santa Rosa, Santa Monica +4 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07098338·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

for Solid Tumors

Sites in Santa Rosa, Fountain Valley +15 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06431594·Phase 1·Recruiting·Listed May 2024

Apply to this trial

Oncology Clinical Trials in Santa Rosa, CA

44 clinical trials for Oncology

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

Conditions in Oncology (Santa Rosa, CA)